FIELD: chemistry.
SUBSTANCE: claimed are novel pyrazole derivatives of formula II 
or its pharmaceutically acceptable salts, where C ring is selected from phenyl or pyridinyl ring and R2, R2', Rx and Ry are such as said in given description. C ring has ortho-substituent and is optionally substituted in non-ortho positions. R2 and R2' , optionally taken with their intermediate atoms, form condensed ring system, such s indazole ring, and Rx and Ry, optionally taken together with their intermediate atoms, form condensed ring system, such a quinazoline ring.
EFFECT: possibility to use compositions as inhibitors of protein kinases as inhibitors GSK-3 and other kinases and apply them for protein kinase-mediated diseases.
41 cl, 8 tbl, 423 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLE DERIVATIVES APPLICABLE AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2355688C2 |
| PYRAZOLE DERIVATIVES, USEFUL AS INHIBITORS OF PROTEIN KINASE | 2001 |
|
RU2332415C2 |
| CASPASE INHIBITORS AND USE THEREOF | 2004 |
|
RU2372335C2 |
| 6-PHENYL-1H-IMIDAZO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES AS CATEPSIN K AND S INHIBITORS | 2007 |
|
RU2400482C2 |
| PYRID-2-ONES APPLICABLE AS PROTEIN KINASE INHIBITORS OF TEC FAMILY FOR TREATING INFLAMMATORY, PROLIFERATIVE AND IMMUNOLOGICALLY MEDIATED DISEASES | 2005 |
|
RU2423351C2 |
| AZAINDOLES, USEFUL AS INHIBITORS OF JAK AND OTHER PROTEINKINASES | 2005 |
|
RU2403252C2 |
| PYRROLOPYRIDINES EFFECTIVE AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2435769C2 |
| CASPASE INHIBITORS AND USE THEREOF | 2005 |
|
RU2382780C2 |
| 4,5-DIHYDRO-[1,2,4]TRIAZOLO[4,3-F]PTERIDINES AS PROTEIN KINASE Plk1 INHIBITORS FOR TREATING PROLIFERATIVE DISEASES | 2007 |
|
RU2441006C2 |
| MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2005 |
|
RU2528046C2 |
